K. Hesse

High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.

D. Cooper, K. Samaras, K. Petoumenos, 2017, AIDS.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

B. Hirschel, D. Cooper, A. Calmy, 2009, The Journal of infectious diseases.

Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts

D. Cooper, M. Law, A. Calmy, 2007, HIV medicine.

Factors affecting outcomes after supermicrosurgical lymphovenous anastomosis in a defined patient population1.

A. Stepniewski, C. Taeger, L. Prantl, 2019, Clinical hemorheology and microcirculation.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients

D. Cooper, J. Amin, K. Hesse, 2010, Antiviral therapy.